Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection.
about
Supramaximal dose of candesartan in proteinuric renal diseasePosttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNAComputational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.Urinary concentration of monocyte chemoattractant protein-1 in idiopathic glomerulonephritis: a long-term follow-up study.Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity.Endoplasmic reticulum stress implicated in the development of renal fibrosisCellular and molecular mechanisms of renal fibrosis.Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritisAngiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen R.The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus.Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.Losartan chemistry and its effects via AT1 mechanisms in the kidneyInflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.Resveratrol ameliorates renal injury in spontaneously hypertensive rats by inhibiting renal micro-inflammation.Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.Candesartan effect on inflammation in hypertension.Renal Artery Stenosis: New Findings from the CORAL Trial.
P2860
Q24649685-46FB8C31-73BB-4188-A00A-636CDAEFADFEQ28114829-1731730D-5089-4FA9-ACFC-EEC87A838DBEQ30278668-307539E6-CF43-400F-B0C4-0363B74D0153Q31149874-864E19B6-178B-4F42-A9B6-369CE73860A1Q34979668-2E1698C9-8490-4532-9850-BDAD5843283DQ35882857-3EAC3E3B-E070-444E-B70E-1E563731A96FQ35903772-5C465D2C-D3B5-42C1-ACEA-256A22E60565Q36373025-101B285E-CF98-4C6D-BAA6-6B60CCC210D3Q36677632-66EA1A5D-072E-40D6-939B-838B5969A054Q37164522-3FED5826-56C1-4D3E-AC4D-E3F5C22A41FAQ37208119-1F8AE6D3-03B0-4B22-990C-63C1EA592FECQ37574913-661AFB49-A8D7-4605-AE92-B9E5AB14D155Q37595616-577247B5-0B7E-4951-AEE8-B6A77C7DC779Q37891878-615883F8-2E96-46C8-A1C2-56587EC66DF0Q38713058-688EE0E4-D667-41C6-8F2A-590F6D4F4E83Q41652967-255785EB-0FD9-4BF9-9FFB-4AD4D38451B2Q41857602-6E82728E-FD6E-45F7-97F4-B564DF8E4035Q42429995-CEFCF883-4A9F-4290-8CD0-D334E31530CAQ43193920-FB5CF4F1-6EA0-4E20-9485-E63B7F094D92Q47871490-D3D250F2-A360-4CBF-874C-4D2F9438B852
P2860
Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Long-term, high-dosage candesa ...... nhemodynamic renal protection.
@en
Long-term, high-dosage candesa ...... nhemodynamic renal protection.
@nl
type
label
Long-term, high-dosage candesa ...... nhemodynamic renal protection.
@en
Long-term, high-dosage candesa ...... nhemodynamic renal protection.
@nl
prefLabel
Long-term, high-dosage candesa ...... nhemodynamic renal protection.
@en
Long-term, high-dosage candesa ...... nhemodynamic renal protection.
@nl
P2093
P356
P1476
Long-term, high-dosage candesa ...... nhemodynamic renal protection.
@en
P2093
Abdlla Rifai
Evelyn M Tolbert
Lance D Dworkin
Rujun Gong
P304
P356
10.1681/ASN.2006070770
P577
2007-02-07T00:00:00Z